Consortium on Translational Research in Early Detection of Liver Cancer (Clinical and Research Centers (U01) (RFA CA 17 025)

 

Opportunity Information:

  • The Department of Health and Human Services, National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Consortium on Translational Research in Early Detection of Liver Cancer (Clinical and Research Centers (U01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394.
  • This funding opportunity was created on Aug 21, 2017.
  • Applicants must submit their applications by Oct 24, 2017.
  • Each selected applicant is eligible to receive up to $550,000.00 in funding.
  • The number of recipients for this funding is limited to 5 candidate(s).
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
Browse more opportunities from the same agency: Department of Health and Human Services, National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Implementation of Invasive Palnt Projects at Lake Mead National Recreation Area

Previous opportunity: Cultural Landscape Preservation Interns

Grant Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 17 025) also looked into and applied for these:

Funding Number Funding Title
RFA CA 17 028 Coordinating Center for the Consortium of Translational Research in Early Detection of Liver Cancer (U24)
RFA CA 17 032 Minority-Patient Derived Xenograft (PDX) Development and Trial Center (PDTC) Network (U54)
RFA CA 17 042 Research Centers for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (UM1)
RFA CA 17 043 Coordinating Center for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (U24)
RFA CA 17 044 Mechanisms of Cancer Drug Resistance and Sensitivity: Coordinating Center (U24)
RFA CA 17 039 Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS): Coordinating Center (U24)
RFA CA 18 001 The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
RFA CA 18 002 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)
RFA CA 18 003 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)
RFA CA 18 004 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)
RFA CA 18 005 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)
PAR 18 221 Fast-Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3 Clinical Trial Optional)
RFA CA 18 009 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trials Optional)
RFA CA 18 010 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trials Optional)
RFA CA 18 008 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)
RFA CA 18 007 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trials Optional)
RFA CA 18 006 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trials Optional)
RFA DA 18 020 NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3, Clinical Trial Optional)
PA 18 496 Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet)(Admin Suppl - Clinical Trial Not Allowed)
RFA DA 18 023 Identification of Biomarkers of HIV-1 Pathogenesis and Substance Abuse Comorbidity (R01- Clinical Trial Not Allowed)

 

Grant Application Guides and Resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

apply for grants

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 17 025", eligibility, application service, and/or application tips? Submit an inquiry below:

First Name
Last Name
Email Address
Phone Number

 

Ask a Question:

Grant Alerts

 

Application Process

Step 1

Self assessment. Grants are available to government, education, public housing, and not for profit organizations. If you are a small business, your business must exceed SBA's size standards.

Step 2

Review the funding details for the opportunity (RFA CA 17 025) and check/verify your eligibility.

Step 3

Register as an individual or as an organization and obtain your grants.gov account.

Step 4

Prepare your application package. Utilize grants.gov's workspace collaboration feature if needed. Submit your application and obtain your unique tracking number.

Step 5

Funding officials will review your application package. Use your tracking number to view and check on the status of your application.

Previous Opportunities